These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17380730)

  • 1. [Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness].
    Murata K; Tokura Y
    J UOEH; 2007 Mar; 29(1):63-71. PubMed ID: 17380730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
    Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
    J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
    Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
    J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K; Hermann J; Blume U; Gollnick H; Hahn H; Haustein UF; Orfanos CE
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
    Del Rosso JQ; Schmidt NF
    Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical clindamycin in the management of acne vulgaris.
    Guay DR
    Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of topical antibiotics for acne treatment.
    Toyoda M; Morohashi M
    Dermatology; 1998; 196(1):130-4. PubMed ID: 9557247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment.
    Kumar A; Agarwal SP; Ahuja A; Ali J; Choudhry R; Baboota S
    Pharmazie; 2011 Feb; 66(2):111-4. PubMed ID: 21434572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M; Nakagawa T; Fukamachi K; Nakamura M; Tokura Y
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
    Amin K; Riddle CC; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
    Taylor GA; Shalita AR
    Am J Clin Dermatol; 2004; 5(4):261-5. PubMed ID: 15301572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.